These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32281318)

  • 1. Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying.
    Yoo JH
    J Korean Med Sci; 2020 Apr; 35(14):e150. PubMed ID: 32281318
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.
    Hartog N; Holsworth A; Rajasekaran S
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):122-123. PubMed ID: 33161152
    [No Abstract]   [Full Text] [Related]  

  • 3. Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy.
    Kumar S; Sharma V; Priya K
    Am J Emerg Med; 2021 Mar; 41():244-246. PubMed ID: 32505474
    [No Abstract]   [Full Text] [Related]  

  • 4. Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment.
    Lung T; Sakem B; Risch M; Nydegger U
    Transfus Apher Sci; 2021 Jun; 60(3):103108. PubMed ID: 33678561
    [No Abstract]   [Full Text] [Related]  

  • 5. Thinking more about therapy with convalescent plasma for COVID-19 patients.
    Han G; Zhou YH
    Hum Vaccin Immunother; 2020 Nov; 16(11):2601-2603. PubMed ID: 32643512
    [No Abstract]   [Full Text] [Related]  

  • 6. Convalescent plasma to treat COVID-19: clinical experience and efficacy.
    Pei S; Yuan X; Zhang Z; Yao R; Xie Y; Shen M; Li B; Chen X; Yin M
    Aging (Albany NY); 2021 Mar; 13(6):7758-7766. PubMed ID: 33735836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy.
    Gachoud D; Bertelli C; Rufer N
    Br J Haematol; 2023 Jan; 200(2):e25-e27. PubMed ID: 36354067
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients.
    Franchini M; Casadevall A; Senefeld JW; Joyner MJ; Sullivan DJ; Focosi D
    Semin Thromb Hemost; 2024 Jun; 50(4):648-653. PubMed ID: 37984358
    [No Abstract]   [Full Text] [Related]  

  • 9. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.
    Pau AK; Aberg J; Baker J; Belperio PS; Coopersmith C; Crew P; Grund B; Gulick RM; Harrison C; Kim A; Lane HC; Masur H; Sheikh V; Singh K; Yazdany J; Tebas P;
    Ann Intern Med; 2021 Jan; 174(1):93-95. PubMed ID: 32976026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic.
    Dassarma B; Tripathy S; Matsabisa M
    Transfus Clin Biol; 2021 Feb; 28(1):123-127. PubMed ID: 33285298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
    Casadevall A; Henderson JP; Joyner MJ; Pirofski LA
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33621214
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of convalescent plasma in the therapy of COVID-19].
    Körper S; Seifried E; Schrezenmeier H
    Dtsch Med Wochenschr; 2023 Mar; 148(7):423-426. PubMed ID: 36940693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
    Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
    Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.
    Fabricius MM; Dandachi D
    Mo Med; 2021; 118(1):74-80. PubMed ID: 33551490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study.
    Wu Y; Hong K; Ruan L; Yang X; Zhang J; Xu J; Pan S; Ren L; Chen L; Huang C; Shang Y
    Virol Sin; 2020 Dec; 35(6):768-775. PubMed ID: 32865701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
    Harris E
    JAMA; 2023 Nov; 330(20):1945. PubMed ID: 37938859
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma.
    Wright Z; Bersabe A; Eden R; Bradley J; Cap A
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):66-68. PubMed ID: 32682684
    [No Abstract]   [Full Text] [Related]  

  • 18. Convalescent plasma for COVID-19 - encouraging signals of efficacy.
    Casadevall A; Tobian AAR
    Br J Haematol; 2021 Feb; 192(4):681-682. PubMed ID: 33524158
    [No Abstract]   [Full Text] [Related]  

  • 19. Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
    Zimmerli A; Monti M; Fenwick C; Eckerle I; Beigelman-Aubry C; Pellaton C; Jaton K; Dumas D; Stamm GM; Infanti L; Andreu-Ullrich H; Germann D; Mean M; Vollenweider P; Stadelmann R; Prella M; Comte D; Guery B; Gachoud D; Rufer N
    Front Immunol; 2021; 12():613502. PubMed ID: 33968017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations.
    Focosi D; Franchini M
    Expert Rev Vaccines; 2022 Jul; 21(7):877-884. PubMed ID: 34015243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.